References
Original article
Park, J. W. et al. Risk-benefit analysis of primary prophylaxis against Pneumocystis jirovecii pneumonia in patients with rheumatic diseases receiving rituximab. Arthritis Rheumatol. https://doi.org/10.1002/art.42541 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Onuora, S. PJP prophylaxis with rituximab. Nat Rev Rheumatol 19, 395 (2023). https://doi.org/10.1038/s41584-023-00982-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-023-00982-w
- Springer Nature Limited